{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T19:59:08Z","timestamp":1788897548535,"version":"build-2803163510"},"reference-count":134,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,3,19]],"date-time":"2021-03-19T00:00:00Z","timestamp":1616112000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Microbiol."],"abstract":"<jats:p>Our understanding of the function of bacterial carbonic anhydrases (CAs, EC 4.2.1.1) has increased significantly in the last years. CAs are metalloenzymes able to modulate CO<jats:sub>2<\/jats:sub>, HCO<jats:sub>3<\/jats:sub><jats:sup>\u2013<\/jats:sup> and H<jats:sup>+<\/jats:sup> concentration through their crucial role in catalysis of reversible CO<jats:sub>2<\/jats:sub> hydration (CO<jats:sub>2<\/jats:sub> + H<jats:sub>2<\/jats:sub>O \u21c4 HCO<jats:sub>3<\/jats:sub><jats:sup>\u2013<\/jats:sup> + H<jats:sup>+<\/jats:sup>). In all living organisms, CA activity is linked to physiological processes, such as those related to the transport and supply of CO<jats:sub>2<\/jats:sub> or HCO<jats:sub>3<\/jats:sub><jats:sup>\u2013<\/jats:sup>, pH homeostasis, secretion of electrolytes, biosynthetic processes and photosynthesis. These important processes cannot be ensured by the very low rate of the non-catalyzed reaction of CO<jats:sub>2<\/jats:sub> hydration. It has been recently shown that CAs are important biomolecules for many bacteria involved in human infections, such as <jats:italic>Vibrio cholerae<\/jats:italic>, <jats:italic>Brucella suis<\/jats:italic>, <jats:italic>Salmonella enterica<\/jats:italic>, <jats:italic>Pseudomonas aeruginosa<\/jats:italic>, and <jats:italic>Helicobacter pylori<\/jats:italic>. In these species, CA activity promotes microorganism growth and adaptation in the host, or modulates bacterial toxin production and virulence. In this review, recent literature in this research field and some of the above-mentioned issues are discussed, namely: (<jats:italic>i<\/jats:italic>) the implication of CAs from bacterial pathogens in determining the microorganism growth and virulence; (<jats:italic>ii<\/jats:italic>) the druggability of these enzymes using classical CA inhibitors (CAIs) of the sulfonamide-type as examples; (<jats:italic>iii<\/jats:italic>) the role played by <jats:italic>Helicobacter pylori<\/jats:italic> CAs in the acid tolerance\/adaptation of the microbe within the human abdomen; (<jats:italic>iv<\/jats:italic>) the role of CAs played in the outer membrane vesicles spawned by <jats:italic>H. pylori<\/jats:italic> in its planktonic and biofilm phenotypes; (<jats:italic>v<\/jats:italic>) the possibility of using <jats:italic>H. pylori<\/jats:italic> CAIs in combination with probiotic strains as a novel anti-ulcer treatment approach. The latter approach may represent an innovative and successful strategy to fight gastric infections in the era of increasing resistance of pathogenic bacteria to classical antibiotics.<\/jats:p>","DOI":"10.3389\/fmicb.2021.629163","type":"journal-article","created":{"date-parts":[[2021,3,19]],"date-time":"2021-03-19T06:43:33Z","timestamp":1616136213000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":63,"title":["Carbonic Anhydrases: New Perspectives on Protein Functional Role and Inhibition in Helicobacter pylori"],"prefix":"10.3389","volume":"12","author":[{"given":"Cristina","family":"Campestre","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Viviana","family":"De Luca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simone","family":"Carradori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rossella","family":"Grande","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincenzo","family":"Carginale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Scaloni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudiu T.","family":"Supuran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clemente","family":"Capasso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2021,3,19]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"3043","DOI":"10.1016\/j.bmc.2016.05.016","article-title":"Synthesis of 4-(thiazol-2-ylamino)-benzenesulfonamides with carbonic anhydrase I, II and IX inhibitory activity and cytotoxic effects against breast cancer cell lines.","volume":"24","author":"Abdel Gawad","year":"2016","journal-title":"Bioorg. Med. Chem."},{"key":"B2","doi-asserted-by":"publisher","first-page":"4111","DOI":"10.1128\/IAI.00409-09","article-title":"Bicarbonate induces Vibrio cholerae virulence gene expression by enhancing ToxT activity.","volume":"77","author":"Abuaita","year":"2009","journal-title":"Infect. Immun."},{"key":"B3","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1038\/nsb0697-490","article-title":"Crystal structure of the anti-bacterial sulfonamide drug target dihydropteroate synthase.","volume":"4","author":"Achari","year":"1997","journal-title":"Nat. Struct. Biol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"2065","DOI":"10.1021\/bc100288c","article-title":"Bishydrazide glycoconjugates for lectin recognition and capture of bacterial pathogens.","volume":"21","author":"Adak","year":"2010","journal-title":"Bioconjug. Chem."},{"key":"B5","doi-asserted-by":"publisher","first-page":"322","DOI":"10.20506\/rst.16.2.1018","article-title":"Risk and the food safety chain: animal health, public health and the environment.","volume":"16","author":"Ahl","year":"1997","journal-title":"Rev. Sci. Tech."},{"key":"B6","doi-asserted-by":"publisher","first-page":"52","DOI":"10.3109\/14756366.2013.877897","article-title":"Inhibition of human carbonic anhydrase isozymes I, II, IX and XII with a new series of sulfonamides incorporating aroylhydrazone-, [1,2,4]triazolo[3,4-b][1,3,4]thiadiazinyl- or 2-(cyanophenylmethylene)-1,3,4-thiadiazol-3(2H)-yl moieties.","volume":"30","author":"Alafeefy","year":"","journal-title":"J. Enzyme Inhib. Med. Chem."},{"key":"B7","doi-asserted-by":"publisher","first-page":"592","DOI":"10.3109\/14756366.2014.957202","article-title":"Inhibition studies of quinazoline-sulfonamide derivatives against the gamma-CA (PgiCA) from the pathogenic bacterium, Porphyromonas gingivalis.","volume":"30","author":"Alafeefy","year":"","journal-title":"J. Enzyme Inhib. Med. Chem."},{"key":"B8","doi-asserted-by":"publisher","first-page":"1430","DOI":"10.1126\/science.1081919","article-title":"Disruption of the epithelial apical-junctional complex by Helicobacter pylori CagA.","volume":"300","author":"Amieva","year":"2003","journal-title":"Science"},{"key":"B9","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.1021\/acsmedchemlett.8b00334","article-title":"Famotidine, an antiulcer agent, srongly inhibits Helicobacter pylori and human carbonic anhydrases.","volume":"9","author":"Angeli","year":"2018","journal-title":"ACS Med. Chem. Lett."},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.3390\/ijms20235844","article-title":"Strategies to overcome antimicrobial resistance (AMR) making use of non-essential target inhibitors: a review.","volume":"20","author":"Annunziato","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"B11","doi-asserted-by":"publisher","first-page":"1904","DOI":"10.1002\/cmdc.201600180","article-title":"Discovery of new potential anti-infective compounds based on carbonic anhydrase inhibitors by rational target-focused repurposing approaches.","volume":"11","author":"Annunziato","year":"2016","journal-title":"ChemMedChem"},{"key":"B12","doi-asserted-by":"publisher","first-page":"1404","DOI":"10.2174\/138955712804586657","article-title":"A review of antimycobacterial drugs in development.","volume":"12","author":"Asif","year":"2012","journal-title":"Mini. Rev. Med. Chem."},{"key":"B13","doi-asserted-by":"publisher","first-page":"1314","DOI":"10.1080\/19490976.2020.1754118","article-title":"Amoxicillin or tetracycline in bismuth-containing quadruple therapy as first-line treatment for Helicobacter pylori infection.","volume":"11","author":"Bang","year":"2020","journal-title":"Gut Microbes"},{"key":"B14","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1111\/joim.12782","article-title":"Biofilm formation - what we can learn from recent developments.","volume":"284","author":"Bjarnsholt","year":"2018","journal-title":"J. Intern. Med."},{"key":"B15","doi-asserted-by":"publisher","first-page":"2003","DOI":"10.1556\/oh.2010.28982","article-title":"Helicobacter pylori - 2010.","volume":"151","author":"Buzas","year":"2010","journal-title":"Orv. Hetil."},{"key":"B16","doi-asserted-by":"publisher","first-page":"527","DOI":"10.3109\/14756366.2015.1051042","article-title":"The history and rationale of using carbonic anhydrase inhibitors in the treatment of peptic ulcers. in memoriam Ioan Puscas (1932-2015).","volume":"31","author":"Buzas","year":"2016","journal-title":"J. Enzyme Inhib. Med. Chem."},{"key":"B17","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1517\/13543776.2013.778245","article-title":"Anti-infective carbonic anhydrase inhibitors: a patent and literature review.","volume":"23","author":"Capasso","year":"2013","journal-title":"Expert Opin. Ther. Pat."},{"key":"B18","doi-asserted-by":"publisher","first-page":"379","DOI":"10.3109\/14756366.2013.787422","article-title":"Sulfa and trimethoprim-like drugs - antimetabolites acting as carbonic anhydrase, dihydropteroate synthase and dihydrofolate reductase inhibitors.","volume":"29","author":"Capasso","year":"2014","journal-title":"J. Enzyme Inhib. Med. Chem."},{"key":"B19","doi-asserted-by":"publisher","first-page":"325","DOI":"10.3109\/14756366.2014.910202","article-title":"An overview of the alpha-, beta- and gamma-carbonic anhydrases from bacteria: can bacterial carbonic anhydrases shed new light on evolution of bacteria?","volume":"30","author":"Capasso","year":"","journal-title":"J. Enzyme Inhib. Med. Chem."},{"key":"B20","doi-asserted-by":"publisher","first-page":"2130","DOI":"10.1517\/14728222.2015.1067685","article-title":"An overview of the selectivity and efficiency of the bacterial carbonic anhydrase inhibitors.","volume":"22","author":"Capasso","year":"","journal-title":"Curr. Med. Chem."},{"key":"B21","doi-asserted-by":"publisher","first-page":"1689","DOI":"10.2174\/0929867321666141012174921","article-title":"Bacterial, fungal and protozoan carbonic anhydrases as drug targets.","volume":"19","author":"Capasso","year":"","journal-title":"Expert Opin. Ther. Targets"},{"key":"B22","doi-asserted-by":"publisher","first-page":"2359","DOI":"10.2174\/1568026616666160413135522","article-title":"An overview of the carbonic anhydrases from two pathogens of the oral cavity: Streptococcus mutans and Porphyromonas gingivalis.","volume":"16","author":"Capasso","year":"2016","journal-title":"Curr. Top. Med. Chem."},{"key":"B23","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1080\/13543776.2020.1830059","article-title":"Biofilm and quorum sensing inhibitors: the road so far.","volume":"30","author":"Carradori","year":"2020","journal-title":"Expert Opin. Ther. Pat."},{"key":"B24","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1016\/j.gassur.2005.10.019","article-title":"Identification of Helicobacter pylori biofilms in human gastric mucosa.","volume":"10","author":"Carron","year":"2006","journal-title":"J. Gastrointest. Surg."},{"key":"B25","doi-asserted-by":"publisher","first-page":"1721","DOI":"10.1021\/jm300031j","article-title":"Dithiocarbamates strongly inhibit carbonic anhydrases and show antiglaucoma action in vivo.","volume":"55","author":"Carta","year":"","journal-title":"J. Med. Chem."},{"key":"B26","doi-asserted-by":"publisher","first-page":"1868","DOI":"10.1039\/c2cc16395k","article-title":"Dithiocarbamates: a new class of carbonic anhydrase inhibitors. crystallographic and kinetic investigations.","volume":"48","author":"Carta","year":"","journal-title":"Chem. Commun."},{"key":"B27","doi-asserted-by":"publisher","first-page":"6649","DOI":"10.1016\/j.bmcl.2009.10.009","article-title":"Carbonic anhydrase inhibitors. Characterization and inhibition studies of the most active beta-carbonic anhydrase from Mycobacterium tuberculosis, Rv3588c.","volume":"19","author":"Carta","year":"2009","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"B28","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.4155\/fmc.14.68","article-title":"Sulfonamides and their isosters as carbonic anhydrase inhibitors.","volume":"6","author":"Carta","year":"2014","journal-title":"Future Med. Chem."},{"key":"B29","doi-asserted-by":"publisher","first-page":"686","DOI":"10.3109\/14756366.2013.842233","article-title":"Sulfonamides incorporating fluorine and 1,3,5-triazine moieties are effective inhibitors of three beta-class carbonic anhydrases from Mycobacterium tuberculosis.","volume":"29","author":"Ceruso","year":"2014","journal-title":"J. Enzyme Inhib. Med. Chem."},{"key":"B30","doi-asserted-by":"publisher","first-page":"57","DOI":"10.4103\/phrev.phrev_21_17","article-title":"Developing new antimicrobial therapies: are synergistic combinations of plant extracts\/compounds with conventional antibiotics the solution?","volume":"11","author":"Cheesman","year":"2017","journal-title":"Pharmacogn. Rev."},{"key":"B31","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.1111\/imj.12902","article-title":"Antibiotic resistance: are we all doomed?","volume":"45","author":"Collignon","year":"2015","journal-title":"Intern. Med. J."},{"key":"B32","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1110\/ps.46301","article-title":"Crystal structure of E. coli beta-carbonic anhydrase, an enzyme with an unusual pH-dependent activity.","volume":"10","author":"Cronk","year":"2001","journal-title":"Protein Sci."},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.f2136","article-title":"Incentives for developing new antibiotics or antimicrobial strategies.","volume":"346","author":"Dahle","year":"2013","journal-title":"BMJ"},{"key":"B34","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.jinorgbio.2011.11.017","article-title":"(In)organic anions as carbonic anhydrase inhibitors.","volume":"111","author":"De Simone","year":"2012","journal-title":"J. Inorg. Biochem."},{"key":"B35","doi-asserted-by":"publisher","first-page":"2002","DOI":"10.1016\/j.bmcl.2015.02.068","article-title":"Crystal structure of the most catalytically effective carbonic anhydrase enzyme known, SazCA from the thermophilic bacterium Sulfurihydrogenibium azorense.","volume":"25","author":"De Simone","year":"2015","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"B36","doi-asserted-by":"publisher","first-page":"2291","DOI":"10.1016\/j.bmcl.2015.04.037","article-title":"Sulfonamide inhibition study of the beta-class carbonic anhydrase from the caries producing pathogen Streptococcus mutans.","volume":"25","author":"Dedeoglu","year":"2015","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"B37","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1080\/14756366.2016.1217856","article-title":"Cloning, expression and purification of the complete domain of the eta-carbonic anhydrase from Plasmodium falciparum.","volume":"31","author":"Del Prete","year":"","journal-title":"J. Enzyme Inhib. Med. Chem."},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.3390\/molecules25112564","article-title":"Anion inhibition studies of the beta-carbonic anhydrase from Escherichia coli.","volume":"25","author":"Del Prete","year":"","journal-title":"Molecules"},{"key":"B39","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1080\/14756366.2020.1755852","article-title":"Bacterial iota-carbonic anhydrase: a new active class of carbonic anhydrase identified in the genome of the Gram-negative bacterium Burkholderia territorii.","volume":"35","author":"Del Prete","year":"","journal-title":"J. Enzyme Inhib. Med. Chem."},{"key":"B40","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.1016\/j.bmc.2016.01.037","article-title":"Sulfonamide inhibition studies of the beta-carbonic anhydrase from the pathogenic bacterium Vibrio cholerae.","volume":"24","author":"Del Prete","year":"","journal-title":"Bioorg. Med. Chem."},{"key":"B41","doi-asserted-by":"publisher","first-page":"4184","DOI":"10.1016\/j.bmcl.2016.07.060","article-title":"Cloning, expression, purification and sulfonamide inhibition profile of the complete domain of the eta-carbonic anhydrase from Plasmodium falciparum.","volume":"26","author":"Del Prete","year":"","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"B42","doi-asserted-by":"publisher","first-page":"1941","DOI":"10.1016\/j.bmcl.2016.03.014","article-title":"Comparison of the sulfonamide inhibition profiles of the alpha-, beta- and gamma-carbonic anhydrases from the pathogenic bacterium Vibrio cholerae.","volume":"26","author":"Del Prete","year":"","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"B43","doi-asserted-by":"publisher","first-page":"1150","DOI":"10.1107\/S0907444913007208","article-title":"X-ray structure of the first \u2018extremo-alpha-carbonic anhydrase\u2019, a dimeric enzyme from the thermophilic bacterium Sulfurihydrogenibium yellowstonense YO3AOP1.","volume":"69","author":"Di Fiore","year":"2013","journal-title":"Acta Crystallogr. D Biol. Crystallogr."},{"key":"B44","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1080\/14756366.2016.1187143","article-title":"A substituted sulfonamide and its Co(II), Cu(II), and Zn(II) complexes as potential antifungal agents.","volume":"31","author":"Diaz","year":"2016","journal-title":"J. Enzyme Inhib. Med. Chem."},{"key":"B45","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1089\/fpd.2014.1865","article-title":"Multidrug-resistant pathogens in the food supply.","volume":"12","author":"Doyle","year":"2015","journal-title":"Foodborne Pathog. Dis."},{"key":"B46","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1177\/1756283X13503514","article-title":"Lactobacillus reuteri in management of Helicobacter pylori infection in dyspeptic patients: a double-blind placebo-controlled randomized clinical trial.","volume":"7","author":"Emara","year":"2014","journal-title":"Therap. Adv. Gastroenterol."},{"key":"B47","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.1111\/imj.13642","article-title":"Healthcare-acquired infections: prevention strategies.","volume":"47","author":"Fernando","year":"2017","journal-title":"Intern. Med. J."},{"key":"B48","doi-asserted-by":"publisher","first-page":"2449","DOI":"10.1107\/S1399004715018635","article-title":"Crystal structure and kinetic studies of a tetrameric type II beta-carbonic anhydrase from the pathogenic bacterium Vibrio cholerae.","volume":"71","author":"Ferraroni","year":"2015","journal-title":"Acta Crystallogr. D Biol. Crystallogr."},{"key":"B49","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/j.ympev.2008.01.005","article-title":"Evolution of structure in gamma-class carbonic anhydrase and structurally related proteins.","volume":"47","author":"Fu","year":"2008","journal-title":"Mol. Phylogenet. Evol."},{"key":"B50","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1111\/j.1365-2672.2012.05351.x","article-title":"Helicobacter pylori biofilm: a protective environment for bacterial recombination.","volume":"113","author":"Grande","year":"2012","journal-title":"J. Appl. Microbiol."},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2015.01369","article-title":"Helicobacter pylori ATCC 43629\/NCTC 11639 Outer Membrane Vesicles (OMVs) from biofilm and planktonic phase associated with extracellular DNA (eDNA).","volume":"6","author":"Grande","year":"2015","journal-title":"Front. Microbiol."},{"key":"B52","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1111\/2049-632X.12158","article-title":"Temporal expression of agrB, cidA, and alsS in the early development of S. aureus UAMS-1 biofilm formation and the structural role of extracellular DNA and carbohydrates.","volume":"70","author":"Grande","year":"2014","journal-title":"Pathog. Dis."},{"key":"B53","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1080\/13543776.2020.1830060","article-title":"Antibiotic resistance and bacterial biofilm.","volume":"30","author":"Grande","year":"2020","journal-title":"Expert Opin. Ther. Pat."},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1093\/femsle\/fny192","article-title":"Small extracellular particles with big potential for horizontal gene transfer: membrane vesicles and gene transfer agents.","volume":"365","author":"Grull","year":"2018","journal-title":"FEMS Microbiol. Lett."},{"key":"B55","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1017\/ice.2016.95","article-title":"Media stories on NICU outbreaks lead to an increased prescription rate of third-line antibiotics in the community of neonatal care.","volume":"37","author":"Hartel","year":"2016","journal-title":"Infect. Control. Hosp. Epidemiol."},{"key":"B56","doi-asserted-by":"publisher","first-page":"1548","DOI":"10.1016\/j.bmcl.2010.01.081","article-title":"Carbonic anhydrase inhibitors. inhibition of transmembrane isoforms IX, XII, and XIV with less investigated anions including trithiocarbonate and dithiocarbamate.","volume":"20","author":"Innocenti","year":"2010","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"B57","doi-asserted-by":"crossref","first-page":"2094","DOI":"10.1038\/s41396-019-0426-8","article-title":"A new widespread subclass of carbonic anhydrase in marine phytoplankton.","volume":"13","author":"Jensen","year":"2019","journal-title":"ISME J."},{"key":"B58","doi-asserted-by":"publisher","first-page":"9540","DOI":"10.1021\/acs.jmedchem.0c00734","article-title":"Optimization of acetazolamide-based scaffold as potent inhibitors of vancomycin-resistant enterococcus.","volume":"63","author":"Kaur","year":"2020","journal-title":"J. Med. Chem."},{"key":"B59","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.semcdb.2015.02.006","article-title":"Gram-negative and gram-positive bacterial extracellular vesicles.","volume":"40","author":"Kim","year":"2015","journal-title":"Semin. Cell. Dev. Biol."},{"key":"B60","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1080\/14756366.2017.1295451","article-title":"Brucella suis carbonic anhydrases and their inhibitors: towards alternative antibiotics?","volume":"32","author":"Kohler","year":"2017","journal-title":"J. Enzyme Inhib. Med. Chem."},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2018.00423","article-title":"Updates in the clinical development of epacadostat and other indoleamine 2,3-dioxygenase 1 inhibitors (IDO1) for human cancers.","volume":"8","author":"Komiya","year":"2018","journal-title":"Front. Oncol."},{"key":"B62","doi-asserted-by":"publisher","first-page":"5018","DOI":"10.1128\/JB.184.18.5018-5026.2002","article-title":"Carbonic anhydrase is essential for growth of Ralstonia eutropha at ambient CO(2) concentrations.","volume":"184","author":"Kusian","year":"2002","journal-title":"J. Bacteriol."},{"key":"B63","first-page":"235","article-title":"Potential effects of rational prescribing on national health care spending: more than half a billion dollars in annual savings.","volume":"62","author":"Littman","year":"2016","journal-title":"Can. Fam. Physician"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2018.01502","article-title":"Gram-positive bacterial extracellular vesicles and their impact on health and disease.","volume":"9","author":"Liu","year":"2018","journal-title":"Front. Microbiol."},{"key":"B65","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1097\/INF.0000000000001383","article-title":"Characterization of the gastric microbiota in a pediatric population according to Helicobacter pylori status.","volume":"36","author":"Llorca","year":"2017","journal-title":"Pediatr. Infect. Dis. J."},{"key":"B66","doi-asserted-by":"publisher","first-page":"976","DOI":"10.1016\/j.bmc.2016.01.019","article-title":"Kinetic and X-ray crystallographic investigations on carbonic anhydrase isoforms I, II, IX and XII of a thioureido analog of SLC-0111.","volume":"24","author":"Lomelino","year":"","journal-title":"Bioorg. Med. Chem."},{"key":"B67","article-title":"Non-classical inhibition of carbonic anhydrase.","volume":"17","author":"Lomelino","year":"","journal-title":"Int. J. Mol. Sci."},{"key":"B68","doi-asserted-by":"crossref","DOI":"10.1016\/j.ceca.2019.102080","article-title":"Pseudomonas aeruginosa \u03b2-carbonic anhydrase, psCA1, is required for calcium deposition and contributes to virulence.","volume":"84","author":"Lotlikar","year":"2019","journal-title":"Cell Calcium"},{"key":"B69","doi-asserted-by":"crossref","DOI":"10.3390\/microorganisms8111653","article-title":"Correlation between the antimicrobial activity and metabolic profiles of cell free supernatants and membrane vesicles produced by Lactobacillus reuteri DSM 17938.","volume":"8","author":"Maccelli","year":"2020","journal-title":"Microorganisms"},{"key":"B70","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1101\/sqb.2016.81.031096","article-title":"A pipeline for drug target identification and validation.","volume":"81","author":"Manchado","year":"2016","journal-title":"Cold Spring Harb. Symp. Quant. Biol."},{"key":"B71","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1126\/science.aar7201","article-title":"Translocation of a gut pathobiont drives autoimmunity in mice and humans.","volume":"359","author":"Manfredo Vieira","year":"2018","journal-title":"Science"},{"key":"B72","doi-asserted-by":"crossref","first-page":"407","DOI":"10.3109\/14756366.2011.641015","article-title":"Dithiocarbamates strongly inhibit the beta-class carbonic anhydrases from Mycobacterium tuberculosis.","volume":"28","author":"Maresca","year":"2013","journal-title":"J. Enzyme Inhib. Med. Chem."},{"key":"B73","doi-asserted-by":"crossref","DOI":"10.1186\/1475-2859-12-71","article-title":"Role of commensal and probiotic bacteria in human health: a focus on inflammatory bowel disease.","volume":"12","author":"Martin","year":"2013","journal-title":"Microb. Cell Fact."},{"key":"B74","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1007\/978-94-007-7359-2_15","article-title":"Carbonic anhydrase inhibitors drug design.","volume":"75","author":"McKenna","year":"2014","journal-title":"Subcell. Biochem."},{"key":"B75","doi-asserted-by":"publisher","first-page":"6415","DOI":"10.1128\/JB.185.21.6415-6424.2003","article-title":"Why is carbonic anhydrase essential to Escherichia coli?","volume":"185","author":"Merlin","year":"2003","journal-title":"J. Bacteriol."},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0127149","article-title":"Structural basis for the iinhibition of Helicobacter pylori alpha-carbonic anhydrase by sulfonamides.","volume":"10","author":"Modak","year":"2015","journal-title":"PLoS One"},{"key":"B77","doi-asserted-by":"publisher","first-page":"11098","DOI":"10.1021\/acs.jmedchem.6b01333","article-title":"Structure-activity relationship for sulfonamide inhibition of Helicobacter pylori alpha-carbonic anhydrase.","volume":"59","author":"Modak","year":"2016","journal-title":"J. Med. Chem."},{"key":"B78","doi-asserted-by":"publisher","first-page":"1660","DOI":"10.1080\/14756366.2019.1663416","article-title":"Anti-Helicobacter pylori activity of ethoxzolamide.","volume":"34","author":"Modak","year":"2019","journal-title":"J. Enzyme Inhib. Med. Chem."},{"key":"B79","doi-asserted-by":"publisher","DOI":"10.3390\/molecules22091430","article-title":"Advances in development of antimicrobial peptidomimetics as potential drugs.","volume":"22","author":"Molchanova","year":"2017","journal-title":"Molecules"},{"key":"B80","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1016\/j.bmcl.2011.12.033","article-title":"Dithiocarbamates are strong inhibitors of the beta-class fungal carbonic anhydrases from Cryptococcus neoformans, Candida albicans and Candida glabrata.","volume":"22","author":"Monti","year":"2012","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"B81","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1007\/s00535-008-2240-3","article-title":"Cloning, polymorphism, and inhibition of beta-carbonic anhydrase of Helicobacter pylori.","volume":"43","author":"Morishita","year":"2008","journal-title":"J. Gastroenterol."},{"key":"B82","author":"Nguyen","year":"2020","journal-title":"Famotidine. 2020 Jul 10. in: StatPearls."},{"key":"B83","doi-asserted-by":"publisher","first-page":"3585","DOI":"10.1016\/j.bmcl.2007.04.063","article-title":"Carbonic anhydrase inhibitors: the beta-carbonic anhydrase from Helicobacter pylori is a new target for sulfonamide and sulfamate inhibitors.","volume":"17","author":"Nishimori","year":"2007","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"B84","doi-asserted-by":"publisher","first-page":"3300","DOI":"10.2174\/138161210793429814","article-title":"The beta-carbonic anhydrases from Mycobacterium tuberculosis as drug targets.","volume":"16","author":"Nishimori","year":"2010","journal-title":"Curr. Pharm. Des."},{"key":"B85","doi-asserted-by":"publisher","first-page":"5023","DOI":"10.1016\/j.bmc.2011.06.038","article-title":"Inhibition studies of the beta-carbonic anhydrases from the bacterial pathogen Salmonella enterica serovar Typhimurium with sulfonamides and sulfamates.","volume":"19","author":"Nishimori","year":"2011","journal-title":"Bioorg. Med. Chem."},{"key":"B86","doi-asserted-by":"publisher","first-page":"622","DOI":"10.2174\/138161208783877875","article-title":"The alpha and beta classes carbonic anhydrases from Helicobacter pylori as novel drug targets.","volume":"14","author":"Nishimori","year":"2008","journal-title":"Curr. Pharm. Des."},{"key":"B87","doi-asserted-by":"publisher","first-page":"2182","DOI":"10.1016\/j.bmcl.2006.01.044","article-title":"Carbonic anhydrase inhibitors: cloning and sulfonamide inhibition studies of a carboxyterminal truncated alpha-carbonic anhydrase from Helicobacter pylori.","volume":"16","author":"Nishimori","year":"2006","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"B88","doi-asserted-by":"publisher","first-page":"2939","DOI":"10.1016\/j.bmc.2014.04.006","article-title":"Sulfonamide inhibition studies of two beta-carbonic anhydrases from the bacterial pathogen Legionella pneumophila.","volume":"22","author":"Nishimori","year":"2014","journal-title":"Bioorg. Med. Chem."},{"key":"B89","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1007\/978-1-62703-005-2_7","article-title":"The Helicobacter pylori cag pathogenicity island.","volume":"921","author":"Noto","year":"2012","journal-title":"Methods Mol. Biol."},{"key":"B90","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1093\/jac\/17.6.689","article-title":"Domagk and the development of the sulphonamides.","volume":"17","author":"Otten","year":"1986","journal-title":"J. Antimicrob. Chemother."},{"key":"B91","doi-asserted-by":"publisher","first-page":"36","DOI":"10.5005\/jp-journals-10018-1310","article-title":"Helicobacter pylori infection and gastric microbiota.","volume":"10","author":"Ozbey","year":"2020","journal-title":"Euroasian J. Hepatogastroenterol."},{"key":"B92","doi-asserted-by":"publisher","first-page":"689","DOI":"10.3109\/14756366.2015.1059333","article-title":"A magnificent enzyme superfamily: carbonic anhydrases, their purification and characterization.","volume":"31","author":"Ozensoy Guler","year":"2016","journal-title":"J. Enzyme Inhib. Med. Chem."},{"key":"B93","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1146\/annurev.micro.57.030502.090720","article-title":"Bacterial biofilms: an emerging link to disease pathogenesis.","volume":"57","author":"Parsek","year":"2003","journal-title":"Annu. Rev. Microbiol."},{"key":"B94","doi-asserted-by":"crossref","DOI":"10.1186\/s13099-020-00358-5","article-title":"Antibacterial activity of ethoxzolamide against Helicobacter pylori strains SS1 and 26695.","volume":"12","author":"Rahman","year":"2020","journal-title":"Gut Pathog."},{"key":"B95","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1093\/ps\/82.4.622","article-title":"Monitoring and identifying antibiotic resistance mechanisms in bacteria.","volume":"82","author":"Roe","year":"2003","journal-title":"Poult. Sci."},{"key":"B96","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1128\/IAI.74.3.1649-1660.2006","article-title":"Salmonella enterica highly expressed genes are disease specific.","volume":"74","author":"Rollenhagen","year":"2006","journal-title":"Infect. Immun."},{"key":"B97","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1080\/14756366.2018.1539716","article-title":"Identification and characterization of the alpha-CA in the outer membrane vesicles produced by Helicobacter pylori.","volume":"34","author":"Ronci","year":"2019","journal-title":"J. Enzyme Inhib. Med. Chem."},{"key":"B98","first-page":"443","article-title":"Third and fourth generation fluoroquinolones.","volume":"22","author":"Rossi","year":"2001","journal-title":"Rev. Med. Brux."},{"key":"B99","doi-asserted-by":"publisher","first-page":"1887","DOI":"10.1016\/S0960-894X(00)00375-9","article-title":"Arylsulfonyl-N,N-diethyl-dithiocarbamates: a novel class of antitumor agents.","volume":"10","author":"Scozzafava","year":"2000","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"B100","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1080\/14756360109162355","article-title":"Arylsulfonyl-N,N-dialkyl-dithiocarbamates as tumor cell growth inhibitors: novel agents targeting beta-tubulin?","volume":"16","author":"Scozzafava","year":"2001","journal-title":"J. Enzyme Inhib."},{"key":"B101","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/S1438-4221(00)80090-9","article-title":"Target-based drug discovery for the development of novel antiinfectives.","volume":"290","author":"Selzer","year":"2000","journal-title":"Int. J. Med. Microbiol."},{"key":"B102","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1111\/j.1523-5378.2005.00306.x","article-title":"Effect of the carbonic anhydrase inhibitor, acetazolamide, on Helicobacter pylori infection in vivo: a pilot study.","volume":"10","author":"Shahidzadeh","year":"2005","journal-title":"Helicobacter"},{"key":"B103","doi-asserted-by":"publisher","first-page":"449","DOI":"10.3109\/14756366.2013.800059","article-title":"3D-QSAR CoMFA studies on sulfonamide inhibitors of the Rv3588c beta-carbonic anhydrase from Mycobacterium tuberculosis and design of not yet synthesized new molecules.","volume":"29","author":"Singh","year":"2014","journal-title":"J. Enzyme Inhib. Med. Chem."},{"key":"B104","doi-asserted-by":"crossref","first-page":"D413","DOI":"10.1093\/nar\/gkx1015","article-title":"Target-Pathogen: a structural bioinformatic approach to prioritize drug targets in pathogens.","volume":"46","author":"Sosa","year":"2018","journal-title":"Nucleic Acids Res."},{"key":"B105","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1038\/nrd2467","article-title":"Carbonic anhydrases: novel therapeutic applications for inhibitors and activators.","volume":"7","author":"Supuran","year":"2008","journal-title":"Nat. Rev. Drug Discov."},{"key":"B106","doi-asserted-by":"publisher","first-page":"759","DOI":"10.3109\/14756366.2012.672983","article-title":"Structure-based drug discovery of carbonic anhydrase inhibitors.","volume":"27","author":"Supuran","year":"2012","journal-title":"J. Enzyme Inhib. Med. Chem."},{"key":"B107","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1080\/14737175.2016.1193009","article-title":"Carbonic anhydrase inhibition and the management of neuropathic pain.","volume":"16","author":"Supuran","year":"","journal-title":"Expert Rev. Neurother."},{"key":"B108","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1517\/17425255.2016.1154534","article-title":"Drug interaction considerations in the therapeutic use of carbonic anhydrase inhibitors.","volume":"12","author":"Supuran","year":"","journal-title":"Expert Opin. Drug Metab. Toxicol."},{"key":"B109","doi-asserted-by":"crossref","first-page":"345","DOI":"10.3109\/14756366.2015.1122001","article-title":"How many carbonic anhydrase inhibition mechanisms exist?","volume":"31","author":"Supuran","year":"","journal-title":"J. Enzyme Inhib. Med. Chem."},{"key":"B110","article-title":"Legionella pneumophila carbonic anhydrases: underexplored antibacterial drug targets.","volume":"5","author":"Supuran","year":"","journal-title":"Pathogens"},{"key":"B111","doi-asserted-by":"crossref","first-page":"2023","DOI":"10.1042\/BCJ20160115","article-title":"Structure and function of carbonic anhydrases.","volume":"473","author":"Supuran","year":"","journal-title":"Biochem. J."},{"key":"B112","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1080\/17460441.2017.1253677","article-title":"Advances in structure-based drug discovery of carbonic anhydrase inhibitors.","volume":"12","author":"Supuran","year":"","journal-title":"Expert Opin. Drug Discov."},{"key":"B113","doi-asserted-by":"publisher","DOI":"10.3390\/molecules22101642","article-title":"Special issue: sulfonamides.","volume":"22","author":"Supuran","year":"","journal-title":"Molecules"},{"key":"B114","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1517\/14728222.2014.991312","article-title":"The eta-class carbonic anhydrases as drug targets for antimalarial agents.","volume":"19","author":"Supuran","year":"2015","journal-title":"Expert Opin. Ther. Targets"},{"key":"B115","doi-asserted-by":"publisher","first-page":"1254","DOI":"10.1080\/14756366.2016.1201479","article-title":"New light on bacterial carbonic anhydrases phylogeny based on the analysis of signal peptide sequences.","volume":"31","author":"Supuran","year":"2016","journal-title":"J. Enzyme Inhib. Med. Chem."},{"key":"B116","doi-asserted-by":"publisher","DOI":"10.3390\/metabo7040056","article-title":"An overview of the bacterial carbonic anhydrases.","volume":"7","author":"Supuran","year":"2017","journal-title":"Metabolites"},{"key":"B117","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1080\/13543776.2018.1497161","article-title":"Biomedical applications of prokaryotic carbonic anhydrases.","volume":"28","author":"Supuran","year":"2018","journal-title":"Expert Opin. Ther. Pat."},{"key":"B118","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1080\/13543776.2020.1811853","article-title":"Antibacterial carbonic anhydrase inhibitors: an update on the recent literature.","volume":"30","author":"Supuran","year":"2020","journal-title":"Expert Opin. Ther. Pat."},{"key":"B119","doi-asserted-by":"publisher","first-page":"2245","DOI":"10.1016\/j.bbagen.2018.07.020","article-title":"Targeting Helicobacter pylori urease activity and maturation: in-cell high-throughput approach for drug discovery.","volume":"1862","author":"Tarsia","year":"2018","journal-title":"Biochim. Biophys. Acta Gen. Subj."},{"key":"B120","doi-asserted-by":"publisher","DOI":"10.1155\/2012\/324549","article-title":"Dispensabilities of carbonic anhydrase in proteobacteria.","volume":"2012","author":"Ueda","year":"2012","journal-title":"Int. J. Evol. Biol."},{"key":"B121","doi-asserted-by":"publisher","first-page":"3550","DOI":"10.1016\/j.bmcl.2015.06.079","article-title":"Sulfonamide inhibition studies of the gamma-carbonic anhydrase from the Antarctic bacterium Pseudoalteromonas haloplanktis.","volume":"25","author":"Vullo","year":"","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"B122","doi-asserted-by":"publisher","first-page":"1728","DOI":"10.1016\/j.bmc.2015.02.045","article-title":"Sulfonamide inhibition studies of the gamma-carbonic anhydrase from the Antarctic cyanobacterium Nostoc commune.","volume":"23","author":"Vullo","year":"","journal-title":"Bioorg. Med. Chem."},{"key":"B123","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1016\/j.bmc.2014.12.009","article-title":"Sulfonamide inhibition studies of the eta-class carbonic anhydrase from the malaria pathogen Plasmodium falciparum.","volume":"23","author":"Vullo","year":"","journal-title":"Bioorg. Med. Chem."},{"key":"B124","doi-asserted-by":"publisher","first-page":"3591","DOI":"10.1016\/j.bmcl.2011.04.105","article-title":"Inhibition studies with anions and small molecules of two novel beta-carbonic anhydrases from the bacterial pathogen Salmonella enterica serovar Typhimurium.","volume":"21","author":"Vullo","year":"2011","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"B125","doi-asserted-by":"publisher","first-page":"6706","DOI":"10.1016\/j.bmcl.2013.10.037","article-title":"Anion inhibition studies of a beta-carbonic anhydrase from Clostridium perfringens.","volume":"23","author":"Vullo","year":"2013","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"B126","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1111\/j.1469-0691.2005.01264.x","article-title":"The emergence and implications of metallo-beta-lactamases in Gram-negative bacteria.","volume":"11","author":"Walsh","year":"2005","journal-title":"Clin. Microbiol. Infect."},{"key":"B127","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1038\/nrmicro2202","article-title":"Metabolism, cell growth and the bacterial cell cycle.","volume":"7","author":"Wang","year":"2009","journal-title":"Nat. Rev. Microbiol."},{"key":"B128","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1016\/S0889-8553(05)70139-4","article-title":"Gastric pathology associated with Helicobacter pylori.","volume":"29","author":"Warren","year":"2000","journal-title":"Gastroenterol. Clin. North Am."},{"key":"B129","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1002\/cmdc.200600121","article-title":"Helicobacter: the ease and difficulty of a new discovery (Nobel lecture).","volume":"1","author":"Warren","year":"2006","journal-title":"ChemMedChem"},{"key":"B130","author":"Watford","year":"2020","journal-title":"Bacterial DNA Mutations. in: StatPearls."},{"key":"B131","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1631\/jzus.2003.0232","article-title":"Purification and relationship with gastric disease of a 130 kDa (CagA) protein of Helicobacter pylori.","volume":"4","author":"Ye","year":"2003","journal-title":"J. Zhejiang Univ. Sci."},{"key":"B132","doi-asserted-by":"publisher","DOI":"10.1631\/jzus.2003.0232","article-title":"Biofilm formation by Helicobacter pylori and its involvement for antibiotic resistance.","volume":"2015","author":"Yonezawa","year":"2015","journal-title":"Biomed. Res. Int."},{"key":"B133","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1155\/2015\/914791","article-title":"Endogenous murine microbiota member Faecalibaculum rodentium and its human homologue protect from intestinal tumour growth.","volume":"5","author":"Zagato","year":"2020","journal-title":"Nat. Microbiol."},{"key":"B134","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1038\/s41564-019-0649-5","article-title":"Diagnosis and follow-up of chronic atrophic gastritis.","volume":"59","author":"Zhu","year":"2020","journal-title":"Chin. J. Intern. Med."}],"container-title":["Frontiers in Microbiology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmicb.2021.629163\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,3,19]],"date-time":"2021-03-19T06:43:56Z","timestamp":1616136236000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmicb.2021.629163\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3,19]]},"references-count":134,"alternative-id":["10.3389\/fmicb.2021.629163"],"URL":"https:\/\/doi.org\/10.3389\/fmicb.2021.629163","relation":{},"ISSN":["1664-302X"],"issn-type":[{"value":"1664-302X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,3,19]]},"article-number":"629163"}}